Clinical Trial Update: Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating thrombolysis and deferoxamine for acute ischemic stroke due to middle cerebral artery occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Deferoxamine (deferoxamine)
• Thrombolysis

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: Ischemic Stroke, Acute | Phase 2 | Status: COMPLETED